Rational Vaccines, Inc.

We are an investigational-stage infectious disease company focused on combating all diseases resulting from herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) infections. Using our proprietary technology, we are developing rationally engineered, live attenuated viral immunotherapeutic and prophylactic vaccine candidates. Our aim is to help improve lives by reducing the suffering of those infected and reduce the spread of the virus. Our goal is to revolutionize the treatment, prevention, and diagnosis of herpes and herpes-related diseases worldwide. We envision a future where the world is free of herpes. Yet herpes is not routinely screened for, and despite decades of attempts, the current standard of care is failing many patients. There is still no cure, nor is there an effective herpes vaccine.